PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462932
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1462932
Strep Throat Treatment Market size was valued at USD 2,118.5 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.
Strep throat, also referred to as Group A Streptococcal (GAS) pharyngitis, is a bacterial infection affecting the throat and tonsils caused by Streptococcus pyogenes bacteria. If left untreated, it can lead to severe complications. Various treatment options are available for strep throat, with the most common being oral antibiotics such as penicillin or amoxicillin. These antibiotics effectively eradicate the bacteria responsible for the infection and are typically prescribed for a duration of 10 days, providing prompt relief from symptoms and preventing further spread of the infection. Additionally, throat lozenges or sprays containing anesthetic agents like benzocaine offer temporary relief from throat discomfort.
Strep Throat Treatment Market- Market Dynamics
Rise in strep throat cases, especially among children and adolescents to propel market demand
With a rise in strep throat cases, especially among children and adolescents, the demand for effective treatment options is increasing. Seasonal fluctuations in cases often lead to heightened market activity during peak periods. Increased awareness through public health campaigns and educational initiatives has resulted in a greater number of individuals seeking medical attention and treatment upon experiencing symptoms, thereby boosting the demand for diagnostic and therapeutic interventions. Technological advancements in rapid diagnostic tests have facilitated quicker and more accurate diagnosis, leading to timely treatments and driving market growth. Ongoing developments in antibiotic end Userulations are essential due to evolving resistance patterns, with a focus on enhancing effectiveness while minimizing resistance. Stewardship programs advocating judicious antibiotic use also impact market dynamics by addressing concerns over resistance. School health policies mandating antibiotic treatment for children with strep throat before returning to school indirectly drive demand for treatments. Global health initiatives aimed at managing and preventing infectious diseases further underscore the importance of addressing conditions like strep throat, influencing market dynamics. For example, data from the National Library of Medicine indicates that pharyngitis accounts for over 40 million healthcare provider visits annually, with most individuals experiencing multiple viral upper respiratory tract infections, including pharyngitis, per year.
Strep Throat Treatment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)
Based on Diagnosis segmentation, antibody tests was predicted to show maximum market share in the year 2023
Based on End User segmentation, hospitals was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Strep Throat Treatment Market is segmented on the basis of Diagnosis, Product Type, End User, and Region.
The market is divided into four categories based on Diagnosis: antibody tests, physical examinations, throat cultures, and other modalities. Antibody tests are projected to hold the largest share in this category during the forecast period, driven by the increasing reliance on these diagnostic procedures to detect the presence of the disease.
The market is divided into four categories based on End User: hospitals, diagnostic laboratories, specialty clinics, and other healthcare facilities. Among these, diagnostic laboratories are anticipated to contribute significantly to revenue generation throughout the forecast period. Hospitals play a central role in the diagnosis and treatment of strep throat due to their comprehensive healthcare services and specialized facilities. Hospitals often have well-equipped laboratories capable of conducting antibody tests and throat cultures, allowing for prompt and accurate diagnosis. Additionally, hospitals provide a range of treatment options, including antibiotic therapy and supportive care, to manage strep throat effectively. Their multidisciplinary approach to healthcare ensures that patients receive comprehensive treatment tailored to their individual needs.
Strep Throat Treatment Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
In the Strep Throat Treatment market, companies are increasingly adopting partnership strategies to enhance their market presence and expand their product offerings. Collaborations with pharmaceutical companies, healthcare providers, research institutions, and government agencies allow companies to leverage complementary expertise, resources, and networks to develop innovative treatments, improve diagnostic tools, and streamline distribution channels. These partnerships enable companies to capitalize on emerging opportunities, address unmet medical needs, and provide comprehensive solutions for the effective management of strep throat.
In July 2022, Taiho Pharmaceutical Co., Ltd., a pharmaceutical company, introduced the PITAS throat troche series in Singapore. These film-type troches adhere to the roof of the mouth and effectively alleviate throat pain and swelling.
GLOBAL STREP THROAT TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT
Pfizer Inc.
Sanofi
Astrazeneca
Novartis AG
Bayer AG
GSK plc
Melinta Therapeutics
Amgen Inc.
Others